European Medicines Agency reviews the availability of emergency use in individual countries before approval for Celltrion Corona treatment
Celltrion Pharmaceutical recorded 233.5 billion won in sales last year … “The highest performance since the incorporation of Celltrion Group”
“Flyed in the Corona Crisis” Celltrion Pharmaceuticals, record highs in sales, operating profit, and net profit last year
[김창수의 e뉴스 브리핑] Celltrion corona treatment’Recyrona’, initiated a preliminary review of the product approval of the European Medicines Agency
![[김창수의 e뉴스 브리핑] Celltrion corona treatment’Recyrona’, initiated a preliminary review of the product approval of the European Medicines Agency](https://www.fetv.co.kr/data/photos/20210208/art_16142395142854_69ee58.png "[김창수의 e뉴스 브리핑] Celltrion corona treatment’Recyrona’, initiated a preliminary review of the product approval of the European Medicines Agency")
